SEI Investments’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,659
Closed -$178K 2808
2024
Q4
$178K Sell
32,659
-10,368
-24% -$66.7K ﹤0.01% 2496
2024
Q3
$358K Buy
43,027
+22,357
+108% +$193K ﹤0.01% 2291
2024
Q2
$148K Sell
20,670
-45,593
-69% -$394K ﹤0.01% 2493
2024
Q1
$574K Sell
66,263
-3,643
-5% -$24.6K ﹤0.01% 2067
2023
Q4
$458K Sell
69,906
-47,711
-41% -$308K ﹤0.01% 2140
2023
Q3
$1.18M Buy
117,617
+23,584
+25% +$259K ﹤0.01% 1833
2023
Q2
$1.17M Sell
94,033
-19,517
-17% -$263K ﹤0.01% 1833
2023
Q1
$1.59M Buy
113,550
+37,813
+50% +$543K ﹤0.01% 1716
2022
Q4
$1.08M Buy
75,737
+8,662
+13% +$136K ﹤0.01% 1726
2022
Q3
$1.71M Sell
67,075
-103,695
-61% -$2.6M ﹤0.01% 1611
2022
Q2
$4.74M Buy
170,770
+11,541
+7% +$366K 0.01% 1123
2022
Q1
$5.55M Buy
159,229
+11,079
+7% +$371K 0.01% 1047
2021
Q4
$6.19M Sell
148,150
-1,995
-1% -$80.8K 0.01% 1019
2021
Q3
$7.35M Sell
150,145
-113,259
-43% -$5.52M 0.02% 906
2021
Q2
$11M Buy
263,404
+169,101
+179% +$6.55M 0.02% 679
2021
Q1
$3.06M Buy
94,303
+61,029
+183% +$2.02M 0.01% 1268
2020
Q4
$831K Buy
+33,274
New +$927K ﹤0.01% 1764

Other funds holding MRVI

SEI Investments's MRVI Position: Q1 2025 in Review

SEI Investments sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 32,659 shares — an estimated $178K sold.

SEI Investments first reported a position in MRVI in Q4 2020 and held it in 17 quarters. The position peaked at $11M in Q2 2021. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • SEI Investments reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • SEI Investments sold 32,659 Maravai LifeSciences shares in Q1 2025, an estimated $178K.
  • SEI Investments first reported a position in Maravai LifeSciences in Q4 2020 and held it in 17 quarters.
  • SEI Investments's Maravai LifeSciences position peaked at $11M in Q2 2021.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.